Option Care Health, Inc. (OPCH)

Market Cap	4.05B
Revenue (ttm)	4.78B
Net Income (ttm)	208.87M
Shares Out	170.18M
EPS (ttm)	1.19
PE Ratio	20.06
Forward PE	19.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	760,015
Open	24.12
Previous Close	24.12
Day's Range	23.76 - 24.20
52-Week Range	21.39 - 34.63
Beta	1.32
Analysts	Buy
Price Target	31.20 (+31.04%)
Earnings Date	Oct 30, 2024

About OPCH

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rhe...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: John Rademacher
• Employees: 7,802
• Stock Exchange: NASDAQ
• Ticker Symbol: OPCH
• Website: https://www.optioncarehealth.com

Financial Performance

In 2023, Option Care Health's revenue was $4.30 billion, an increase of 9.06% compared to the previous year's $3.94 billion. Earnings were $267.09 million, an increase of 77.40%.

Analyst Forecast

According to 5 analysts, the average rating for OPCH stock is "Buy." The 12-month stock price forecast is $31.2, which is an increase of 31.04% from the latest price.

Price Target

$31.2

(31.04% upside)

Analyst Consensus: Buy